Reviva Pharmaceuticals Holdings, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
RVPH Nasdaq 2834 www.revivapharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Reviva Pharmaceuticals Holdings, Inc.

Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Feb 4th, 2025 1:00 pm
Reviva to Participate in the 2025 BIO CEO & Investor Conference - Jan 30th, 2025 1:00 pm
Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit - Jan 7th, 2025 1:00 pm
RVPH: Preliminary OLE Readout - Dec 23rd, 2024 9:22 am
Applied Therapeutics Appoints John H. Johnson as Executive Chairman - Dec 20th, 2024 12:00 pm
Reviva Pharmaceuticals Strengthens Financial Position with Offering - Dec 19th, 2024 11:33 am
Top Midday Decliners - Dec 17th, 2024 7:29 pm
Reviva Announces Proposed Public Offering - Dec 16th, 2024 10:18 pm
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia - Dec 16th, 2024 1:00 pm
RVPH: Year-End OLE Update - Nov 19th, 2024 9:25 am
Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Nov 14th, 2024 10:25 pm
Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia - Nov 12th, 2024 1:00 pm
Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024 - Nov 6th, 2024 1:00 pm
Reviva to Participate in the UBS Global Healthcare Conference - Oct 31st, 2024 12:00 pm
Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit - Oct 8th, 2024 12:00 pm
Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - Oct 2nd, 2024 12:30 pm
Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference - Sep 26th, 2024 12:30 pm
RVPH: RECOVER Biomarker KOL Event - Sep 16th, 2024 3:43 pm
Reviva Announces New Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia - Sep 9th, 2024 12:00 pm
Reviva to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Sep 4th, 2024 12:00 pm